Vaxtex Cotfab

What does Vaxtex Cotfab do?

Vaxtex Cotfab Ltd is a Micro Cap company in the Garments & Apparels industry, incorporated in 2005, with recent quarterly net sales of 5 Cr and net profit of 1 Cr as of March 2025. Key metrics include a P/E of 18.00 and a market cap of Rs 18 Cr.

Overview:<BR>Vaxtex Cotfab Ltd operates in the Garments & Apparels industry and is classified as a Micro Cap company.<BR><BR>History:<BR>Vaxtex Cotfab Limited was incorporated in 2005 under the name "Foolproof Vyapaar Private Limited" in Kolkata, West Bengal. The company changed its name to "Vaxtex Cotfab Private Limited" in December 2015. The latest quarterly results reported net sales and net profit for the period ending March 2025.<BR><BR>Financial Snapshot:<BR>- Net Sales: 5 Cr (Quarterly Results - Mar 2025)<BR>- Net Profit: 1 Cr (Quarterly Results - Mar 2025)<BR>- Market Cap: Rs 18 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 18.00<BR>- Industry P/E: 23<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: 0.57<BR>- Return on Equity: 4.75%<BR>- Price to Book: 0.97<BR><BR>Contact Details:<BR>No Company Details Available. Registrar Address: Not available.

Who are in the management team of Vaxtex Cotfab?

As of March 2019, the management team of Vaxtex Cotfab includes Khushat Gupta and Mithleshkumar M Agrawal as Managing Directors, along with Mithleshkumar M Agrawal as Director, and Dhavalbhai Pravinbhai Patel, Poonam Pravinbhai Panchal, and Pranav Manoj Vajani as Independent Directors.

As of March 2019, the management team of Vaxtex Cotfab includes the following individuals:<BR><BR>1. Khushat Gupta - Managing Director<BR>2. Mithleshkumar M Agrawal - Managing Director<BR>3. Mithleshkumar M Agrawal - Director<BR>4. Dhavalbhai Pravinbhai Patel - Independent Director<BR>5. Poonam Pravinbhai Panchal - Independent Director<BR>6. Pranav Manoj Vajani - Independent Director<BR><BR>These members form the board of directors overseeing the company's operations.

When is the next results date for Vaxtex Cotfab?

No Upcoming Board Meetings

What is the bonus history of the Vaxtex Cotfab?

Vaxtex Cotfab announced a 2:3 bonus issue with an ex-date of December 27, 2021, and a record date of December 28, 2021, allowing eligible shareholders to receive bonus shares based on this ratio.

Vaxtex Cotfab has a bonus history that includes a 2:3 bonus issue announced with an ex-date of December 27, 2021. The record date for this bonus was December 28, 2021. This means that shareholders on record as of the record date were eligible to receive the bonus shares based on the specified ratio. If you have any further questions about the company or its financials, feel free to ask!

Has Vaxtex Cotfab declared dividend?

No Dividend History Available

Who are the peers of the Vaxtex Cotfab?

Vaxtex Cotfab's peers include Trent, Page Industries, K P R Mill Ltd, Vedant Fashions, Trident, Vivaa Tradecom, Advance Lifes., Adinath Textiles, Globale Tessile, and Sri Nacha. Cott., with varying management risk and growth ratings, and Page Industries showing the highest 1-year return at 26.58%.

Peers: The peers of Vaxtex Cotfab are Trent, Page Industries, K P R Mill Ltd, Vedant Fashions, Trident, Vivaa Tradecom, Advance Lifes., Adinath Textiles, Globale Tessile, and Sri Nacha. Cott.<BR><BR>Quality Snapshot: Excellent management risk is observed at Page Industries, K P R Mill Ltd, and Vedant Fashions, while Good management risk is found at Trent. Average management risk is noted at Trident, and Below Average management risk is seen at Vivaa Tradecom, Advance Lifes., Globale Tessile, and Sri Nacha. Cott. Adinath Textiles does not qualify for management risk assessment. For Growth, Excellent growth is seen at K P R Mill Ltd, while Good growth is noted at Trent. Below Average growth is found at Page Industries, Vedant Fashions, Trident, Vivaa Tradecom, Advance Lifes., Globale Tessile, and Sri Nacha. Cott., with Adinath Textiles not qualifying. In terms of Capital Structure, Excellent is seen at Page Industries and K P R Mill Ltd, while Below Average is noted at Vivaa Tradecom, Advance Lifes., Adinath Textiles, Globale Tessile, and Sri Nacha. Cott., with Trent having a Below Average rating as well.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Page Industries at 26.58%, while the lowest is Vedant Fashions at -24.67%. Vaxtex Cotfab's 1-year return is 0.00%, which is lower than both of these peers. Additionally, the six-month return is negative for K P R Mill Ltd, Vedant Fashions, Trident, Advance Lifes., Globale Tessile, Sri Nacha. Cott.

Is Vaxtex Cotfab overvalued or undervalued?

As of May 9, 2023, Vaxtex Cotfab is considered overvalued and risky, with a PE ratio of 17.82, a price to book value of 0.95, and a concerning EV to EBITDA ratio of -28.55, alongside a recent stock decline of -6.06% compared to the Sensex's gain of 1.65%.

As of 9 May 2023, the valuation grade for Vaxtex Cotfab has moved from very expensive to risky, indicating a shift in perception regarding its market standing. The company is currently assessed as overvalued. Key ratios include a PE ratio of 17.82, a price to book value of 0.95, and a PEG ratio of 0.16, which suggests that despite a relatively low price to book value, the overall valuation metrics reflect significant risk.<BR><BR>In comparison to its peers, Vaxtex Cotfab's PE ratio is similar to that of other companies in the sector, but its EV to EBITDA ratio of -28.55 highlights a concerning trend compared to industry standards. Notably, the company has underperformed in recent weeks, with a stock return of -6.06% over the past week, contrasting sharply with the Sensex's gain of 1.65%. This performance, coupled with a ROCE of -33.65%, reinforces the view that Vaxtex Cotfab is currently overvalued in the market.

What is the technical trend for Vaxtex Cotfab?

As of June 6, 2025, Vaxtex Cotfab's trend is mildly bearish due to daily moving averages, despite some mixed bullish signals from weekly indicators, suggesting a cautious outlook.

As of 6 June 2025, the technical trend for Vaxtex Cotfab has changed from sideways to mildly bearish. The current stance is mildly bearish, primarily driven by the daily moving averages indicating a bearish trend. While the weekly MACD and Bollinger Bands show mildly bullish signals, the monthly indicators are bearish, suggesting a lack of strength in the upward momentum. The KST and OBV on a weekly basis are mildly bullish, but they do not outweigh the bearish signals from the moving averages. Overall, the mixed signals across different time frames indicate a cautious outlook.

Who are the top shareholders of the Vaxtex Cotfab?

The top shareholders of Vaxtex Cotfab are Qmin Industries Limited with 11.22%, Vaxfab Enterprises Limited at 6.49%, and individual investors holding 71.29%. There are no mutual funds or foreign institutional investors involved.

The top shareholders of Vaxtex Cotfab include Qmin Industries Limited, which holds the highest promoter stake at 11.22%. The highest public shareholder is Vaxfab Enterprises Limited, with a holding of 6.49%. Additionally, individual investors collectively hold a significant portion of 71.29%. There are no mutual funds or foreign institutional investors currently holding shares in the company.

How big is Vaxtex Cotfab?

As of 24th July, Vaxtex Cotfab Ltd has a market capitalization of 19.00 Cr, with net sales of 5.25 Cr and a net profit of 0.89 Cr over the latest four quarters. Shareholder's funds are 18.79 Cr, and total assets amount to 48.87 Cr as of March 2024.

As of 24th July, Vaxtex Cotfab Ltd has a market capitalization of 19.00 Cr, categorizing it as a Micro Cap company.<BR><BR>In the latest four quarters, Vaxtex Cotfab reported Net Sales of 5.25 Cr and a Net Profit of 0.89 Cr.<BR><BR>The latest annual period for the balance sheet is March 2024, with Shareholder's Funds amounting to 18.79 Cr and Total Assets of 48.87 Cr.

How has been the historical performance of Vaxtex Cotfab?

Vaxtex Cotfab has experienced significant financial fluctuations, with net sales declining from 75.62 Cr in Mar'23 to 5.25 Cr in Mar'25, leading to negative operating profits. However, there are signs of recovery, as profit after tax improved to 0.88 Cr in Mar'25 from a loss of -8.83 Cr in Mar'24, and cash flow from operations turned positive at 1.00 Cr in Mar'25.

Answer:<BR>The historical performance of Vaxtex Cotfab shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Vaxtex Cotfab's net sales have seen a dramatic decline from 75.62 Cr in Mar'23 to just 5.25 Cr in Mar'25, indicating a downward trend in revenue generation. The total operating income followed a similar pattern, dropping from 75.62 Cr in Mar'23 to 5.25 Cr in Mar'25. This decline in sales has led to negative operating profits, with an operating profit of -0.51 Cr in Mar'25 compared to a positive 3.01 Cr in Mar'22. The profit before tax also reflects this trend, moving from 2.01 Cr in Mar'22 to 0.41 Cr in Mar'25. Despite these challenges, the profit after tax showed a recovery to 0.88 Cr in Mar'25 from a loss of -8.83 Cr in Mar'24. The company's total liabilities decreased from 69.48 Cr in Mar'23 to 48.29 Cr in Mar'25, while total assets also fell from 69.48 Cr to 48.29 Cr in the same period. Cash flow from operating activities remained negative in previous years but turned positive at 1.00 Cr in Mar'25, suggesting improved operational efficiency. Overall, Vaxtex Cotfab's financial performance has been volatile, with significant losses in recent years, but there are signs of recovery in the latest fiscal year.

How has been the historical performance of Vaxtex Cotfab?

Vaxtex Cotfab has faced significant revenue declines, with net sales dropping from 75.62 Cr in Mar'23 to 5.25 Cr in Mar'25, while operating profit remained negative. However, there are signs of recovery in profitability and positive cash flow in the most recent year.

Answer:<BR>The historical performance of Vaxtex Cotfab shows significant fluctuations in key financial metrics over the years.<BR><BR>Breakdown:<BR>Vaxtex Cotfab's net sales have experienced a notable decline, dropping from 75.62 Cr in Mar'23 to just 5.25 Cr in Mar'25. This decline is mirrored in total operating income, which also fell sharply from 75.62 Cr in Mar'23 to 5.25 Cr in Mar'25. The company's total expenditure, excluding depreciation, decreased from 76.00 Cr in Mar'23 to 5.76 Cr in Mar'25, indicating a substantial reduction in operational costs. However, the operating profit (PBDIT) has remained negative, with a loss of 0.51 Cr in Mar'25 compared to a loss of 0.38 Cr in Mar'23. Profit before tax showed a slight recovery, moving from a loss of 8.83 Cr in Mar'24 to a profit of 0.41 Cr in Mar'25, while profit after tax also improved to 0.88 Cr in Mar'25 from a loss of 8.83 Cr in the previous year. The company’s total assets decreased from 69.48 Cr in Mar'23 to 48.29 Cr in Mar'25, and total liabilities also fell from 69.48 Cr to 48.29 Cr during the same period. Cash flow from operating activities was positive at 1.00 Cr in Mar'25, contrasting with a negative cash flow of -47.00 Cr in Mar'24. Overall, Vaxtex Cotfab's financial performance reflects a challenging environment with significant revenue declines but some signs of recovery in profitability and cash flow in the most recent year.

Are Vaxtex Cotfab Ltd latest results good or bad?

Vaxtex Cotfab Ltd's latest results show impressive short-term growth with a 287.77% increase in net sales and a return to profitability; however, concerns about revenue volatility, reliance on non-operating income, and a drastic drop in promoter holding suggest a cautious outlook for sustainability.

Vaxtex Cotfab Ltd's latest results present a mixed picture, showcasing both significant improvements and underlying concerns. On the positive side, the company reported a remarkable 287.77% quarter-on-quarter growth in net sales, reaching ₹8.88 crores in Q3 FY26, and a net profit of ₹3.95 crores, a substantial turnaround from a loss in the previous year. The operating margin also improved dramatically to 26.01%, compared to a negative margin in the prior quarter.<BR><BR>However, these impressive figures are overshadowed by several critical issues. The company has exhibited extreme revenue volatility, with multiple quarters of zero sales prior to this surge. Additionally, a significant portion of the profit in Q3 FY26 came from non-operating income, which raises questions about the sustainability of these earnings. The historical performance shows a long-term decline in sales and profitability, with a five-year sales growth rate of -57.18%.<BR><BR>Moreover, the drastic reduction in promoter holding—from 18.10% to just 0.84%—is a concerning signal about insider confidence in the company's future. While the stock has performed exceptionally well over the past year, the underlying fundamentals suggest that this rally may not be sustainable.<BR><BR>In summary, while Vaxtex Cotfab's latest results show a dramatic improvement in the short term, the company faces significant operational challenges and risks that make the overall outlook cautious. Investors should be wary of the volatility and the reliance on non-operating income for profitability.

Should I buy, sell or hold Vaxtex Cotfab Ltd?

Why is Vaxtex Cotfab Ltd falling/rising?

As of 16-Mar, Vaxtex Cotfab Ltd's stock price is declining at 1.45, down 4.61%, with significant underperformance over various periods. Despite a strong annual return of 93.33%, recent trends show a concerning decline and decreased investor participation.

As of 16-Mar, Vaxtex Cotfab Ltd's stock price is falling, currently at 1.45, which reflects a decrease of 0.07 or 4.61%. The stock has underperformed significantly over various periods, with a 1-week decline of 21.20% and a 1-month drop of 33.79%, compared to the Sensex's declines of 2.58% and 8.85%, respectively. Year-to-date, the stock is down 29.27%, while the Sensex has only fallen by 10.41%. <BR><BR>Despite a strong performance over the past year, where the stock generated a return of 93.33%, recent trends indicate a concerning decline. The stock's performance today has underperformed its sector by 3.26%, and there is a notable decrease in investor participation, with the delivery volume on March 13 falling by 55.42% compared to the 5-day average. Additionally, while the stock is higher than its 200-day moving average, it is lower than the 5-day, 20-day, 50-day, and 100-day moving averages, suggesting a weakening short-term trend.<BR><BR>These factors combined indicate that despite the company's strong financial results and growth in net profit, the stock is currently facing significant downward pressure, leading to its falling price.

Which are the latest news on Vaxtex Cotfab?